+LIFE - MAGNESIO POTASSIO
Food supplement declared in France, declaration No 2023-12-1058
+LIFE - MAGNESIO POTASSIO is a food supplement declared in France. Status: retrait du marché annoncé pour le 4 June 2027. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- Nutramis S.r.l.
- Status
- Retrait du marché annoncé pour le 4 June 2027
- Form
- Comprimé
- Daily dose
- 6 comprimés par jour
Declaration 137715, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 4 June 2027, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Sels de magnésium de l'acide citrique | Magnésium | 250 mg | 300 mg |
| Oxyde de magnésium | Magnésium | 250 mg | 300 mg |
| Citrate de potassium | Potassium | pas de limite (données insuffisantes) | 80 mg |
Additives
E460, E470b, E551
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne pas dépasser la dose journalière recommandée. Les compléments alimentaires ne doivent pas se substituer à une alimentation variée et équilibrée et à un mode de vie sain. Un mode de vie sain et une alimentation variée et équilibrée sont importants. Ne pas laisser à la portée des jeunes enfants. Déconseillé auxpersonnes âgées ou atteintes de néphropathie.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.